Both in Pharmaceuticals
CorMedix vs Aquestive Therapeutics
Over the past year CRMD returned −50.4% and AQST returned −37.5%; their daily moves had a correlation of 0.20.
CRMD −50.4% AQST −37.5%Growth of $1, one year, split-adjusted
| Metric | CRMD | AQST |
|---|---|---|
| Price | $5.66 | $3.80 |
| Market cap | $441.2M | $476.9M |
| Today | +1.80% | −2.06% |
| 1 month | −22.3% | −17.6% |
| 6 months | −29.7% | −10.2% |
| Year to date | −51.3% | −41.2% |
| 1 year | −51.0% | −41.4% |
| Revenue growth (YoY) | +156.5% | +38.1% |
| Gross margin | 75.7% | 70.9% |
| Net margin | 25.5% | −165.5% |
| P/E (TTM) | 2.4× | — |
| Price / sales | 1.0× | 8.8× |
| Net cash | $256.7M | $47.8M |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 54.2% |
| Short % of float | 20.8% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).